Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS)-Reference-Cited by-同舟云学术

Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS)

Published:2013-01 Issue:1 Volume:69 Page:38-43
ISSN:0923-1811
Container-title:Journal of Dermatological Science
language:en
Short-container-title:Journal of Dermatological Science

Author:

Ogawa Kohei,Morito Hironori,Hasegawa Ayako,Daikoku Natsuko,Miyagawa Fumi,Okazaki Aiko,Fukumoto Takaya,Kobayashi Nobuhiko,Kasai Takahiko,Watanabe Hideaki,Sueki Hirohiko,Iijima Masafumi,Tohyama Mikiko,Hashimoto Koji,Asada Hideo

Publisher

Elsevier BV

Subject

Dermatology,Molecular Biology,Biochemistry

Reference21 articles.

1. Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpes viruses and antiviral and antidrug immune responses;Shiohara;Allergol Int,2006

2. A complex interaction between drug allergy and viral infection;Shiohara;Clin Rev Allergy Immunol,2007

3. Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome;Takahashi;J Immunol,2009

4. Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein–Barr virus vector;Imai;J Biol Chem,1996

5. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4;Imai;J Biol Chem,1997

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Adult Patients With Drug Reaction With Eosinophilia and Systemic Symptoms;JAMA Dermatology;2024-01-01

2. Dupilumab to treat drug reaction with eosinophilia and systemic symptoms: A case series;The Journal of Allergy and Clinical Immunology: In Practice;2023-12

3. Analytical Performance of a Novel Latex Turbidimetric Immunoassay, “Nanopia TARC”, for TARC/CCL17 Measurement: A Retrospective Observational Study;Diagnostics;2023-09-13

4. Le DRESS syndrome en 2023;Bulletin de l'Académie Nationale de Médecine;2023-08

5. Recombinant Interleukin‐1 Receptor antagonist is an effective first‐line treatment strategy in new‐onset systemic Juvenile Idiopathic Arthritis, irrespective of HLA‐DRB1 background and IL1RN variants;Arthritis & Rheumatology;2023-07-20